CTRI/2019/08/020868已完成2 期
A DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED TRIAL ON SIDDHARTHAKA YOGA IN THE MANAGEMENT OF MILD & MODERATE DEPRESSIO
SDM Pharmacy Udupi0 个研究点目标入组 160 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients who are diagnosed as suffering from mild and moderate depression
排除标准
- •1.Patients suffering from severe depression
- •2.Patients having suicidal ideation.
- •3.Patients associated with major organic pathologies.
研究者
相似试验
招募中
2 期
To see effetiveness of homoeopathic medicines on chronic rhinosinusitis against placeboCTRI/2012/01/002320Central Council for Research in Homoeopathy120
招募中
不适用
Role of anti cholesterol medicine for fatty liverCTRI/2023/02/049958AIG Hospitals
进行中（未招募）
不适用
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED DETROL LA ADD-ON TO ALPHA-BLOCKER STUDY IN MEN WITH PERSISTENT OVERACTIVE BLADDER SYMPTOMS OF URINARY FREQUENCY AND URGENCY WITH/WITHOUT URGENCY INCONTINENCE AFTER PREVIOUS MONOTHERAPY WITH ALPHA BLOCKER - NDOveractive Bladder in MenMedDRA version: 6.1Level: PTClassification code 10046494EUCTR2005-004452-13-ITPFIZER608
尚未招募
2 期
AYUSH - M3 in MigraineCTRI/2021/12/038548CCRAS
进行中（未招募）
1 期
A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS. - N/AEUCTR2006-001475-38-NLJanssen Cliag Ltd. C/O Johnson & Johnson PRD